Requires health insurers to provide coverage for treatment of tick-borne diseases.
This bill requires health insurers in New Jersey to cover medically necessary treatments for tick-borne diseases, including long-term antibiotic therapy (beyond four weeks) and ongoing testing. It directly affects insurers (hospital, medical, health service corporations, and individual policies) and policyholders diagnosed with conditions like Lyme disease (caused by *borrelia burgdorferi*), chronic infections, or other CDC-recognized tick-borne illnesses. Insurers cannot deny coverage solely because treatment is experimental or uses unapproved drugs, provided the treatment is recognized by medical guidelines or peer-reviewed research. The law applies to all relevant insurance contracts issued or renewed in New Jersey after its effective date.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026
Last action Jan 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Joe Pennacchio
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1320
Scope: NJ
Hi! I can help you understand S 1320. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline